European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections

The Rome Statements

C Mussini, A Antinori, S Bhagani, T Branco, M Brostrom, N Dedes, T Bereczky, E Girardi, D Gökengin, A Horban, K Lacombe, J D Lundgren, L Mendao, A Mocroft, C Oprea, K Porter, D Podlekareva, M Battegay, A d'Arminio Monforte, European Aids Clinical Society & 1 andre Nina Friis-Møller

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

OBJECTIVES: The objective of the 1st European AIDS Clinical Society meeting on Standard of Care in Europe was to raise awareness of the European scenario and come to an agreement on actions that could be taken in the future.

METHODS: Data-driven presentations were given on specific topics followed by interactive panel discussions.

RESULTS: In Eastern European countries, the epidemic is largely driven by injecting drug use, in contrast with Western Europe where the infection mainly occurs through heterosexual contact. A high proportion of people living with HIV remain unaware of their infection. Substantial differences exist in Eastern Europe and Central Asia with respect to treatment coverage, regimen availability and continuity of drug supply. In 2012, tuberculosis case notification rates were 5-10 times higher in Eastern Europe compared with Western Europe, with an alarming proportion of newly diagnosed multi-drug-resistant cases. Hepatitis C is widespread in selected geographical areas and risk groups.

CONCLUSIONS: The key conclusion from the meeting was that a high-priority group of actions could be identified, including: increasing HIV awareness and testing, improving training for health care providers, ensuring equitable patient access to treatments and diagnostics for HIV and comorbidities, and implementing best practices in infection control and treatment of HIV-infected patients coinfected with tuberculosis and hepatitis C virus, for whom direct acting antiviral treatment. should be considered.

OriginalsprogEngelsk
TidsskriftHIV Medicine
Vol/bind17
Udgave nummer6
Sider (fra-til)445-452
ISSN1464-2662
DOI
StatusUdgivet - 2016

Fingeraftryk

Coinfection
Acquired Immunodeficiency Syndrome
HIV
Eastern Europe
Pharmaceutical Preparations
Far East
Heterosexuality
Hepatitis C
Infection Control
Practice Guidelines
Hepacivirus
Health Personnel
Comorbidity

Citer dette

Mussini, C., Antinori, A., Bhagani, S., Branco, T., Brostrom, M., Dedes, N., ... Friis-Møller, N. (2016). European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements. HIV Medicine, 17(6), 445-452. https://doi.org/10.1111/hiv.12347
Mussini, C ; Antinori, A ; Bhagani, S ; Branco, T ; Brostrom, M ; Dedes, N ; Bereczky, T ; Girardi, E ; Gökengin, D ; Horban, A ; Lacombe, K ; Lundgren, J D ; Mendao, L ; Mocroft, A ; Oprea, C ; Porter, K ; Podlekareva, D ; Battegay, M ; d'Arminio Monforte, A ; European Aids Clinical Society ; Friis-Møller, Nina. / European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections : The Rome Statements. I: HIV Medicine. 2016 ; Bind 17, Nr. 6. s. 445-452.
@article{813196875e7c4ecaac69bad9969e94af,
title = "European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements",
abstract = "OBJECTIVES: The objective of the 1st European AIDS Clinical Society meeting on Standard of Care in Europe was to raise awareness of the European scenario and come to an agreement on actions that could be taken in the future.METHODS: Data-driven presentations were given on specific topics followed by interactive panel discussions.RESULTS: In Eastern European countries, the epidemic is largely driven by injecting drug use, in contrast with Western Europe where the infection mainly occurs through heterosexual contact. A high proportion of people living with HIV remain unaware of their infection. Substantial differences exist in Eastern Europe and Central Asia with respect to treatment coverage, regimen availability and continuity of drug supply. In 2012, tuberculosis case notification rates were 5-10 times higher in Eastern Europe compared with Western Europe, with an alarming proportion of newly diagnosed multi-drug-resistant cases. Hepatitis C is widespread in selected geographical areas and risk groups.CONCLUSIONS: The key conclusion from the meeting was that a high-priority group of actions could be identified, including: increasing HIV awareness and testing, improving training for health care providers, ensuring equitable patient access to treatments and diagnostics for HIV and comorbidities, and implementing best practices in infection control and treatment of HIV-infected patients coinfected with tuberculosis and hepatitis C virus, for whom direct acting antiviral treatment. should be considered.",
author = "C Mussini and A Antinori and S Bhagani and T Branco and M Brostrom and N Dedes and T Bereczky and E Girardi and D G{\"o}kengin and A Horban and K Lacombe and Lundgren, {J D} and L Mendao and A Mocroft and C Oprea and K Porter and D Podlekareva and M Battegay and {d'Arminio Monforte}, A and {European Aids Clinical Society} and Nina Friis-M{\o}ller",
note = "{\circledC} 2015 British HIV Association.",
year = "2016",
doi = "10.1111/hiv.12347",
language = "English",
volume = "17",
pages = "445--452",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "6",

}

Mussini, C, Antinori, A, Bhagani, S, Branco, T, Brostrom, M, Dedes, N, Bereczky, T, Girardi, E, Gökengin, D, Horban, A, Lacombe, K, Lundgren, JD, Mendao, L, Mocroft, A, Oprea, C, Porter, K, Podlekareva, D, Battegay, M, d'Arminio Monforte, A, European Aids Clinical Society & Friis-Møller, N 2016, 'European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements', HIV Medicine, bind 17, nr. 6, s. 445-452. https://doi.org/10.1111/hiv.12347

European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections : The Rome Statements. / Mussini, C; Antinori, A; Bhagani, S; Branco, T; Brostrom, M; Dedes, N; Bereczky, T; Girardi, E; Gökengin, D; Horban, A; Lacombe, K; Lundgren, J D; Mendao, L; Mocroft, A; Oprea, C; Porter, K; Podlekareva, D; Battegay, M; d'Arminio Monforte, A; European Aids Clinical Society; Friis-Møller, Nina.

I: HIV Medicine, Bind 17, Nr. 6, 2016, s. 445-452.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections

T2 - The Rome Statements

AU - Mussini, C

AU - Antinori, A

AU - Bhagani, S

AU - Branco, T

AU - Brostrom, M

AU - Dedes, N

AU - Bereczky, T

AU - Girardi, E

AU - Gökengin, D

AU - Horban, A

AU - Lacombe, K

AU - Lundgren, J D

AU - Mendao, L

AU - Mocroft, A

AU - Oprea, C

AU - Porter, K

AU - Podlekareva, D

AU - Battegay, M

AU - d'Arminio Monforte, A

AU - European Aids Clinical Society

AU - Friis-Møller, Nina

N1 - © 2015 British HIV Association.

PY - 2016

Y1 - 2016

N2 - OBJECTIVES: The objective of the 1st European AIDS Clinical Society meeting on Standard of Care in Europe was to raise awareness of the European scenario and come to an agreement on actions that could be taken in the future.METHODS: Data-driven presentations were given on specific topics followed by interactive panel discussions.RESULTS: In Eastern European countries, the epidemic is largely driven by injecting drug use, in contrast with Western Europe where the infection mainly occurs through heterosexual contact. A high proportion of people living with HIV remain unaware of their infection. Substantial differences exist in Eastern Europe and Central Asia with respect to treatment coverage, regimen availability and continuity of drug supply. In 2012, tuberculosis case notification rates were 5-10 times higher in Eastern Europe compared with Western Europe, with an alarming proportion of newly diagnosed multi-drug-resistant cases. Hepatitis C is widespread in selected geographical areas and risk groups.CONCLUSIONS: The key conclusion from the meeting was that a high-priority group of actions could be identified, including: increasing HIV awareness and testing, improving training for health care providers, ensuring equitable patient access to treatments and diagnostics for HIV and comorbidities, and implementing best practices in infection control and treatment of HIV-infected patients coinfected with tuberculosis and hepatitis C virus, for whom direct acting antiviral treatment. should be considered.

AB - OBJECTIVES: The objective of the 1st European AIDS Clinical Society meeting on Standard of Care in Europe was to raise awareness of the European scenario and come to an agreement on actions that could be taken in the future.METHODS: Data-driven presentations were given on specific topics followed by interactive panel discussions.RESULTS: In Eastern European countries, the epidemic is largely driven by injecting drug use, in contrast with Western Europe where the infection mainly occurs through heterosexual contact. A high proportion of people living with HIV remain unaware of their infection. Substantial differences exist in Eastern Europe and Central Asia with respect to treatment coverage, regimen availability and continuity of drug supply. In 2012, tuberculosis case notification rates were 5-10 times higher in Eastern Europe compared with Western Europe, with an alarming proportion of newly diagnosed multi-drug-resistant cases. Hepatitis C is widespread in selected geographical areas and risk groups.CONCLUSIONS: The key conclusion from the meeting was that a high-priority group of actions could be identified, including: increasing HIV awareness and testing, improving training for health care providers, ensuring equitable patient access to treatments and diagnostics for HIV and comorbidities, and implementing best practices in infection control and treatment of HIV-infected patients coinfected with tuberculosis and hepatitis C virus, for whom direct acting antiviral treatment. should be considered.

U2 - 10.1111/hiv.12347

DO - 10.1111/hiv.12347

M3 - Journal article

VL - 17

SP - 445

EP - 452

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 6

ER -